An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance-Reference-Cited by-同舟云学术

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance

Published:2022-12 Issue: Volume:208 Page:105457
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Patel Mira C.,Flanigan Daniel,Feng Chenchen,Chesnokov Anton,Nguyen Ha T.,Elal Anwar Abd,Steel John,Kondor Rebecca J.,Wentworth David E.,Gubareva Larisa V.,Mishin Vasiliy P.

Funder

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference34 articles.

1. Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding;Barman;J. Virol.,2004

2. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins;Corti;Science,2011

3. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide;Deyde;J. Infect. Dis.,2007

4. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay;Eichelberger;Virol. J.,2008

5. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020;Govorkova;Antivir. Res.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors;Antiviral Research;2024-09

2. Multiple transatlantic incursions of highly pathogenic avian influenza clade 2.3.4.4b A(H5N5) virus into North America and spillover to mammals;Cell Reports;2024-07

3. Influenza C virus susceptibility to antivirals with different mechanisms of action;Antimicrobial Agents and Chemotherapy;2024-05-02

4. Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase;Immunity;2024-03

5. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023;The Journal of Infectious Diseases;2023-09-28